🇺🇸 FDA
Patent

US 9821030

LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

granted A61KA61K38/08A61K38/2292

Quick answer

US patent 9821030 (LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERX BIOPHARMACEUTICALS, INC.
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/08, A61K38/2292, A61K47/186, A61K9/0048